Carlo Leonetti

Rome, 00144, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide.

Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 12, 2024

TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.

TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.

Journal: Cell death & disease

Published: May 28, 2024

Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer.

Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer.

Journal: Molecular therapy. Nucleic acids

Published: April 06, 2023

Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use.

Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use.

Journal: International journal of molecular sciences

Published: April 07, 2022

MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.

MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.

Journal: EMBO molecular medicine

Published: March 18, 2022

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 28, 2022

Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.

Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 09, 2021

Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours.

Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours.

Journal: EMBO molecular medicine

Published: May 06, 2021

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 04, 2020

FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma.

FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma.

Journal: Journal of hepatology

Published: June 04, 2020

Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer.

Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer.

Journal: Cancers

Published: June 01, 2020

Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA.

Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA.

Journal: International journal of pharmaceutics

Published: May 26, 2020

Showing 1-12 of 60

Last Updated: 09/26/2026